Skip to main content
ESPR logo

Esperion Therapeutics, Inc.

ESPRNASDAQHealthcareDrug Manufacturers - Specialty & Generic

$3.18Today:- (-)1Y +15.64%

As of Jul 14, 2026 close

Market cap
$799.30M
P/E (TTM)
-
Forward P/E
-
Dividend yield
99.37%
52-week range
$1.80$4.18
Volume (live)
-
Avg. volume (3M)
-

Esperion Therapeutics (ESPR) Financial Ratios

For fiscal 2025 (fiscal year ended Dec 31, 2025), Esperion Therapeutics had debt-to-equity of -1.81 (down from -1.52), a current ratio of 1.54 (up from 1.37) and return on assets of 9.3% (down from 12.4%). A current ratio of 1.54 means current assets exceed current liabilities.

Esperion Therapeutics Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
Forward P/E12.2616.60----
P/S Ratio2.161.302.926.083.903.19
P/B Ratio-2.88-1.11-0.75-1.42-1.55-7.54
Enterprise Value Ratios
EV/Revenue3.422.556.5010.799.263.02
EV/EBITDA22.8515.58----
EV/EBIT22.8915.59----
Profitability & Returns
Return on Assets (ROA)9.30%12.37%-42.86%-35.64%-36.31%-26.73%
Return on Capital Employed (ROCE)36.50%55.70%-313.80%-115.30%-69.30%-46.80%
Leverage & Solvency Ratios
Debt/Equity-1.81-1.52-1.19-1.56-2.63-3.77
Debt/EBITDA8.7010.29----
Liquidity Ratios
Current Ratio1.541.371.292.674.493.68
Quick Ratio1.020.910.842.173.853.37
Efficiency Ratios
Asset Turnover1.001.210.510.240.210.80
Inventory Turnover1.391.322.574.194.76-
Yield & Distribution Ratios
Earnings Yield-2.60%-11.94%-61.54%-50.90%-87.91%-19.81%
FCF Yield-1.50%-5.53%-39.85%-38.08%-86.18%-11.87%
Buyback Yield-11.05%-81.54%-55.26%-129.76%-5.20%-1.42%

Source: Company financial statements from annual and quarterly filings. Data as of Mar 31, 2026. Data sources and methodology

Frequently Asked Questions About Esperion Therapeutics Financial Ratios

What is Esperion Therapeutics's debt-to-equity ratio?

Esperion Therapeutics's debt-to-equity ratio was -1.81 for fiscal 2025 (period ended Dec 31, 2025). It was -1.52 a year earlier.

What is return on equity (ROE)?

Return on equity is net income divided by shareholders' equity. It measures how much profit a company generates from the capital its shareholders have invested. Full definition